Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with relapsing-remitting or secondary progressive multiple sclerosis (MS), confirmed using a specific set of diagnostic standards known as the McDonald 2017 criteria
- People whose MS-related disability falls below a certain level, as measured by a standard MS disability scale (a score below 7 out of 10)
- People who have not had a relapse (a flare-up of MS symptoms) for at least 3 months before joining
- People whose MS medication has remained the same for at least 2 months before joining
- People aged between 18 and 65 years old
- People who speak Dutch, English, or German (depending on which study centre they are attending)
Who may not be able to join:
- People who score very highly on a personality measure of conscientiousness (a score of 65 or above on a specific standardised scale called the BFI-2)
- People who have a current or past brain injury, or any other neurological condition apart from MS
- People who have a psychiatric condition that significantly affects their thinking, memory, or ability to carry out everyday tasks
- People taking medications or using substances that are known to affect thinking or memory
- People in the Dutch part of the study who are having an MRI scan and have a medical reason why an MRI would not be safe for them (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hanneke E Hulst, Prof, Leiden University
Phone: 062 831 93 32
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective cognitive changes between baseline and post-intervention; Subjective cognitive changes between baseline and post-intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.